Emmons Nicole A, Duman Zeki, Erdal Murat Kaan, Hespanha João, Kippin Tod E, Plaxco Kevin W
Department of Psychological and Brain Sciences, University of California, Santa Barbara 93106, United States.
Neuroscience Research Institute, University of California, Santa Barbara 93106, United States.
ACS Pharmacol Transl Sci. 2025 Apr 11;8(5):1416-1423. doi: 10.1021/acsptsci.5c00142. eCollection 2025 May 9.
Electrochemical aptamer-based (EAB) sensors enable the continuous, real-time monitoring of drugs and biomarkers in situ in the blood, brain, and peripheral tissues of live subjects. The real-time concentration information produced by these sensors provides unique opportunities to perform closed-loop, feedback-controlled drug delivery, by which the plasma concentration of a drug can be held constant or made to follow a specific, time-varying profile. Motivated by the observation that the site of action of many drugs is the solid tissues and not the blood, here we experimentally confirm that maintaining constant plasma drug concentrations also produces constant concentrations in the interstitial fluid (ISF). Using an intravenous EAB sensor we performed feedback control over the concentration of doxorubicin, an anthracycline chemotherapeutic, in the plasma of live rats. Using a second sensor placed in the subcutaneous space, we find drug concentrations in the ISF rapidly (30-60 min) match and then accurately (RMS deviation of 8 to 21%) remain at the feedback-controlled plasma concentration, validating the use of feedback-controlled plasma drug concentrations to control drug concentrations in the solid tissues that are the site of drug action. We expanded to pairs of sensors in the ISF, the outputs of the individual sensors track one another with good precision ( = 0.95-0.99), confirming that the performance of in vivo EAB sensors matches that of prior, in vitro validation studies. These observations suggest EAB sensors could prove a powerful new approach to the high-precision personalization of drug dosing.
基于电化学适配体的(EAB)传感器能够在活体受试者的血液、大脑和外周组织中原位连续、实时监测药物和生物标志物。这些传感器产生的实时浓度信息为进行闭环反馈控制药物递送提供了独特机会,通过这种方式可以使药物的血浆浓度保持恒定或遵循特定的随时间变化的曲线。鉴于许多药物的作用部位是实体组织而非血液,在此我们通过实验证实,维持恒定的血浆药物浓度也会使组织间液(ISF)中的浓度保持恒定。我们使用静脉内EAB传感器对活体大鼠血浆中的阿霉素(一种蒽环类化疗药物)浓度进行反馈控制。通过将第二个传感器置于皮下空间,我们发现组织间液中的药物浓度在30至60分钟内迅速匹配,然后准确地(均方根偏差为8%至21%)保持在反馈控制的血浆浓度水平,这验证了利用反馈控制的血浆药物浓度来控制作为药物作用部位的实体组织中的药物浓度的方法。我们将研究扩展到组织间液中的成对传感器,各个传感器的输出能够很好地相互跟踪(相关系数 = 0.95 - 0.99),证实了体内EAB传感器的性能与之前的体外验证研究相当。这些观察结果表明,EAB传感器可能是一种用于药物给药高精度个性化的强大新方法。